DIVITA CHARLES III 4

4 · Teladoc Health, Inc. · Filed Mar 3, 2026

Insider Transaction Report

Form 4

Period: 2022-02-27

Teladoc Health, Inc.TDOC

DIVITA CHARLES III

DirectorCHIEF EXECUTIVE OFFICER

Transactions

Exercise/Conversion
Common Stock
[F1]
2022-02-27+169,107→ 370,143 total
Exercise/Conversion
Common Stock
[F2]
2026-02-27+7,864→ 378,007 total
Sale
Common Stock
[F3]
2026-03-02$5.12/sh−50,145$256,592→ 327,862 total
Exercise/Conversion
Restricted Stock Units
[F1][F4]
2026-02-27−169,107→ 338,215 total
→ Common Stock (169,107 underlying)
Award
Performance Stock Units
[F5][F6][F7]
2026-02-27+23,591→ 23,591 total
→ Common Stock (23,591 underlying)
Exercise/Conversion
Performance Stock Units
[F2][F8]
2026-02-27−7,864→ 15,727 total
→ Common Stock (7,864 underlying)
Award
Restricted Stock Units
[F9][F10]
2026-03-01+692,041→ 692,041 total
→ Common Stock (692,041 underlying)

Footnotes (10)

[F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
[F10]One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
[F2]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
[F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
[F4]On March 1, 2025, the reporting person was granted 507,322 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. The reporting person's previous Form 4 filing incorrectly listed the number of restricted stock units granted as 507,332 instead of 507,322 due to a typo which has been corrected in this Form 4.
[F5]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
[F6]Performance award amount determined based on metrics in respect of the issuer's 2025 financial results.
[F7]The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
[F8]On March 1, 2026, the reporting person earned 23,591 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
[F9]Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

Signature

/s/ Adam C. Vandervoort, Attorney-in-Fact|2026-03-03

Documents

1 file

4
wk-form4_1772572168.xmlPrimary
FORM 4